SAM
Stenahm Asset Management Portfolio holdings
AUM
$229M
This Quarter Return
+9.79%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$163M
AUM Growth
+$163M
(+15%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
6.25%
Top 10 Holdings %
Top 10 Hldgs %
62.99%
Holding
33
New
7
Increased
3
Reduced
6
Closed
7
Top Buys
| 1 |
Teck Resources
TECK
|
$8.27M |
| 2 |
Applied Materials
AMAT
|
$7.9M |
| 3 |
Analog Devices
ADI
|
$6.09M |
| 4 |
Denali Therapeutics
DNLI
|
$3.53M |
| 5 |
United Therapeutics
UTHR
|
$3.46M |
Top Sells
| 1 |
Aclaris Therapeutics
ACRS
|
$7.14M |
| 2 |
Equinix
EQIX
|
$6.46M |
| 3 |
SCR
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
|
$3.89M |
| 4 |
Fate Therapeutics
FATE
|
$2.8M |
| 5 |
Ascendis Pharma
ASND
|
$2.5M |
Sector Composition
| 1 | Technology | 31.4% |
| 2 | Financials | 18.68% |
| 3 | Communication Services | 17.93% |
| 4 | Healthcare | 9.92% |
| 5 | Consumer Discretionary | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Beyond Meat
BYND
$184M
| $16K | 0.01% |
100
| – | – |
|
|
27
Aclaris Therapeutics
ACRS
$219M
| – | – |
-283,500
| Closed | -$7.14M |
|
28
Adverum Biotechnologies
ADVM
$63.2M
| – | – |
-111,000
| Closed | -$1.09M |
|
|
29
Ascendis Pharma
ASND
$12.2B
| – | – |
-19,400
| Closed | -$2.5M |
|
30
Sprott Physical Gold and Silver Trust
CEF
$6.4B
| – | – |
-46,400
| Closed | -$806K |
|
|
31
Fate Therapeutics
FATE
$116M
| – | – |
-33,900
| Closed | -$2.8M |
|
|
GRTS
32
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| – | – |
-150,000
| Closed | -$1.42M |
|
|
SCR
33
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
| – | – |
-145,000
| Closed | -$3.89M |
|